Early research (Phase 1)Study completedNCT05989672
What this trial is testing
A Study on the Reactogenicity, Safety and Immune Response of a Targeted Immunotherapy Against HSV in Healthy Japanese Participants Aged 18-40 Years
Who this might be right for
Herpes Simplex
GlaxoSmithKline 50